Searching for Solutions

The Sure-Fire Option The online portion of a meeting can provide valuable information during a call, and it is essential to some presentations. However, the online portion is also the source of most technical challenges. If your problem is not addressed below, or if you simply do not want to bother with the online portion, then you can still access the audio portion of the CPNP web meeting by calling:

Information and Access to the Genoa Neuropsychiatric Pharmacy Courses Genoa is pleased to offer our pharmacists the opportunity to access neuropsychiatric pharmacy courses in conjunction with the College of Psychiatric and Neurologic Pharmacists (CPNP), a specialty membership association. The objectives of these offerings are to:

Long-acting injectable (LAI) antipsychotics are unique medication formulations used in psychiatric pharmacy to help improve patient outcomes. They offer several benefits compared to oral therapy, including confirmed patient adherence, consistent drug delivery, predictable bioavailability, and prevention of antipsychotic overdose. LAIs are commonly used with the notion that they will decrease relapse rates by improving medication adherence; however, the data is limited.

Clozapine is a second-generation antipsychotic often reserved for use in treatment-resistant schizophrenia. Clozapine is associated with severe neutropenia (previously called agranulocytosis), which requires stringent laboratory monitoring and reporting to an online Risk Evaluation and Mitigation Strategy (REMS) website. Despite its unique effectiveness, compliance to laboratory monitoring requirements and its substantial adverse effect profile may limit clozapine usage.

AAPP has curated a collection of essentials that provides resources, references, and clinical pearls for practitioners beginning to practice in psychiatry. Citations of landmark trials are provided. Additional resources are based on questions psychiatric pharmacy specialists frequently receive and aims to provide evidence-based support of recommendations. This also contains references to support monitoring and management of adverse effects and drug interactions of psychotropic medications.

The American Association of Psychiatric Pharmacists (AAPP) is a professional association representing psychiatric pharmacists, residents and aspiring future psychiatric pharmacists (students). AAPP's members are specialized and highly trained in psychiatry, substance use disorders, psychopharmacology, and mitigation of psychosocial factors.

AAPP apparel and drinkware are available for purchase! Choose from a selection of polos, sweaters, jackets, and more, and enjoy $10 flat rate shipping for your entire order. The store will close March 6th, and all orders will be processed and mailed at that time. Order now and proudly wear your AAPP-branded merchandise at AAPP 2025 in Salt Lake City and year-round!

AAPP is continuing its membership in the Get the Medications Right Institute (GTMRX) in 2025. GTMRX is focused on advancing recognition among providers and payors of the importance of systematic, evidence-based approaches to medications and their rationale use and the urgent need for payment and policy reform to advance access to and payment for person-centered CMM services.

We at AAPP envision a world where every individual with a psychiatric disorder has a care team that includes a psychiatric pharmacist accountable for optimal medication therapy. In much the same way, AAPP hopes to make a real impact by being part of a team of organizations who share a common vision of patient care and the profession. We encourage you to further investigate these partnerships to learn more about how AAPP is working to make an impact.

VitalSource is a leading provider of e-textbook solutions. AAPP provides some of its educational resources through VitalSource to all users to read and annotate the document from nearly any device. It is more convenient than managing a library of PDFs, and it is more accessible than only viewing them online.

While many people who sustain a traumatic brain injury (TBI) recover within weeks or months of their injury, others experience long-term symptoms and disabilities. This public workshop will explore the state of knowledge regarding TBI as a chronic condition and discuss strategies to improve care and outcomes for people living with its longer-term consequences.

AAPP Communities and the associated discussion threads and email list functionality are available to current AAPP members for the purpose of communicating with other AAPP members on matters regarding psychiatric and neurologic pharmacy or medical issues.

AAPP is a member-driven organization, and we currently support several technologies that facilitate the free exchange of information among pharmacists and other health care professionals. To promote a safe, friendly and professional environment, we have documented acceptable behavior and use of data. Please take a moment to read the following terms of use and policies: